Remdesivir
339 results (0.171 seconds)
search results
This Week in Virology
Clinical update with Dr. Daniel Griffin
October 29, 2022 (duration 45m)
[from description] ... (CDC) Distinguishing SARS-CoV-2 persistence and reinfection (CID) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) Novavax triggers potent neutral...
[from content:encoded] ... (CDC) Distinguishing SARS-CoV-2 persistence and reinfection (CID) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) Novavax triggers potent neutral...
October 29, 2022 (duration 45m)
[from description] ... (CDC) Distinguishing SARS-CoV-2 persistence and reinfection (CID) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) Novavax triggers potent neutral...
[from content:encoded] ... (CDC) Distinguishing SARS-CoV-2 persistence and reinfection (CID) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) Novavax triggers potent neutral...
Clinical update with Dr. Daniel Griffin
October 22, 2022 (duration 33m)
[from description] ... (The LANCET) Successful immunomodulators for treatment of COVID-19 (CMI) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) PAXLOVID patient eligib...
[from content:encoded] ... (The LANCET) Successful immunomodulators for treatment of COVID-19 (CMI) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) PAXLOVID patient eligib...
October 22, 2022 (duration 33m)
[from description] ... (The LANCET) Successful immunomodulators for treatment of COVID-19 (CMI) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) PAXLOVID patient eligib...
[from content:encoded] ... (The LANCET) Successful immunomodulators for treatment of COVID-19 (CMI) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) PAXLOVID patient eligib...
Clinical update with Dr. Daniel Griffin
October 15, 2022 (duration 44m)
[from description] ...sease rebound following PAXLOVID (CID) Outpatient treatment with Remdesivir in patients at high risk (OFID) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for provid...
[from content:encoded] ...sease rebound following PAXLOVID (CID) Outpatient treatment with Remdesivir in patients at high risk (OFID) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for provid...
October 15, 2022 (duration 44m)
[from description] ...sease rebound following PAXLOVID (CID) Outpatient treatment with Remdesivir in patients at high risk (OFID) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for provid...
[from content:encoded] ...sease rebound following PAXLOVID (CID) Outpatient treatment with Remdesivir in patients at high risk (OFID) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for provid...
Clinical update with Dr. Daniel Griffin
October 8, 2022 (duration 42m)
[from description] ...ces COVID19 hospitalizations & deaths (EPIC) Paxlovid rebound in COVID19 (NEJM) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) Dr. Griffin’s tre...
[from content:encoded] ...ces COVID19 hospitalizations & deaths (EPIC) Paxlovid rebound in COVID19 (NEJM) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) Dr. Griffin’s tre...
October 8, 2022 (duration 42m)
[from description] ...ces COVID19 hospitalizations & deaths (EPIC) Paxlovid rebound in COVID19 (NEJM) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) Dr. Griffin’s tre...
[from content:encoded] ...ces COVID19 hospitalizations & deaths (EPIC) Paxlovid rebound in COVID19 (NEJM) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) Dr. Griffin’s tre...
Clinical update with Dr. Daniel Griffin
October 1, 2022 (duration 50m)
[from description] ...ion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants, short-course early outpatient Remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the Omicron BA.2 ...
[from content:encoded] ...ion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants, short-course early outpatient Remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the Omicron BA.2 ...
October 1, 2022 (duration 50m)
[from description] ...ion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants, short-course early outpatient Remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the Omicron BA.2 ...
[from content:encoded] ...ion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants, short-course early outpatient Remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the Omicron BA.2 ...
Clinical update with Dr. Daniel Griffin
September 24, 2022 (duration 53m)
[from description] ...subgenomic mRNA detection (J Inf Dis) Quantitative SARS-CoV-2 subgenomic mRNA for Remdesivir treatment (Clin Inf Dis) Anti-spike mucosal IgA (NEJM) BNT262bs against Omicron sublineages (NEJ...
[from content:encoded] ...subgenomic mRNA detection (J Inf Dis) Quantitative SARS-CoV-2 subgenomic mRNA for Remdesivir treatment (Clin Inf Dis) Anti-spike mucosal IgA (NEJM) BNT262bs against Omicron sublineages (NEJ...
September 24, 2022 (duration 53m)
[from description] ...subgenomic mRNA detection (J Inf Dis) Quantitative SARS-CoV-2 subgenomic mRNA for Remdesivir treatment (Clin Inf Dis) Anti-spike mucosal IgA (NEJM) BNT262bs against Omicron sublineages (NEJ...
[from content:encoded] ...subgenomic mRNA detection (J Inf Dis) Quantitative SARS-CoV-2 subgenomic mRNA for Remdesivir treatment (Clin Inf Dis) Anti-spike mucosal IgA (NEJM) BNT262bs against Omicron sublineages (NEJ...
Clinical update with Dr. Daniel Griffin
September 17, 2022 (duration 52m)
[from description] ...) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) SARS-CoV-2 spike is associated with post...
[from content:encoded] ...) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) SARS-CoV-2 spike is associated with post...
September 17, 2022 (duration 52m)
[from description] ...) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) SARS-CoV-2 spike is associated with post...
[from content:encoded] ...) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) SARS-CoV-2 spike is associated with post...
Clinical update with Dr. Daniel Griffin
September 10, 2022 (duration 52m)
[from description] ...ournals) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) Administration of anti–SARS-COV-2 ...
[from content:encoded] ...ournals) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) Administration of anti–SARS-COV-2 ...
September 10, 2022 (duration 52m)
[from description] ...ournals) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) Administration of anti–SARS-COV-2 ...
[from content:encoded] ...ournals) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) Administration of anti–SARS-COV-2 ...
Clinical update with Dr. Daniel Griffin
September 3, 2022 (duration 49m)
[from description] ...ID) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) COVID-19–associated hospitalizations a...
[from content:encoded] ...ID) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) COVID-19–associated hospitalizations a...
September 3, 2022 (duration 49m)
[from description] ...ID) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) COVID-19–associated hospitalizations a...
[from content:encoded] ...ID) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) COVID-19–associated hospitalizations a...
New Books in Law
The Tamiflu Trials: Profit and Public Health
September 2, 2022 (duration 1h3m)
[from description] Before Remdesivir and Hydroxycloroquin there was Tamiflu. To prepare for Swine Flu and Bird Flu, government...
[from itunes:summary] Before Remdesivir and Hydroxycloroquin there was Tamiflu. To prepare for Swine Flu and Bird Flu, government...
[from content:encoded] Before Remdesivir and Hydroxycloroquin there was Tamiflu.To prepare for Swine Flu and Bird Flu, governments...
September 2, 2022 (duration 1h3m)
[from description] Before Remdesivir and Hydroxycloroquin there was Tamiflu. To prepare for Swine Flu and Bird Flu, government...
[from itunes:summary] Before Remdesivir and Hydroxycloroquin there was Tamiflu. To prepare for Swine Flu and Bird Flu, government...
[from content:encoded] Before Remdesivir and Hydroxycloroquin there was Tamiflu.To prepare for Swine Flu and Bird Flu, governments...
Didn't find, what you are looking for? A podcast, an episode is missing? You can provide a feed-URL, that will be added to the database. You can do that here. In case you think, there's a bug, please contact us. Thanks!